Hangzhou Regenovo Biotechnology.
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- Undisclosed
Investors
- 7
About Hangzhou Regenovo Biotechnology.
, Ltd. is a biotechnology company that focuses on the research and development of 3D printing technology in the biomedical field, which won the Vice Chairman Unit of China 3D Printing Technology Industry Alliance, Vice Chairman Unit of Zhejiang Translational Medicine Association, and so on. It has established partnerships with Peking University, OLAY, Fan Beauty Secret, etc., Ltd. The company is committed to providing systematic products and services for scientific research, drug development, regenerative medicine, and personalized medical research and clinical applications. The business includes biological 3D printing systematic equipment, biomaterials and bio-inks, drug development tools for pharmaceutical companies, and treatment methods for patients with tissue and organ defects.
Who invested in Hangzhou Regenovo Biotechnology.
7 investors across 3 rounds
See all investors in Hangzhou Regenovo Biotechnology.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hangzhou Regenovo Biotechnology.
Who invested in Hangzhou Regenovo Biotechnology.?
Hangzhou Regenovo Biotechnology. has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Regenovo Biotechnology. raised?
Hangzhou Regenovo Biotechnology. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Hangzhou Regenovo Biotechnology. last raise money?
Hangzhou Regenovo Biotechnology.'s most recent round on record is a Series B, in Jul 2018.
What does Hangzhou Regenovo Biotechnology. do?
Hangzhou Regenovo Biotechnology. is a biotechnology company.
Where is Hangzhou Regenovo Biotechnology. headquartered?
Hangzhou Regenovo Biotechnology. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Regenovo Biotechnology.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Hangzhou Regenovo Biotechnology.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Hangzhou Regenovo Biotechnology.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.